JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5401
PUT
SharkNinja
SN
$25.6B
| $123K | ﹤0.01% |
+2,400
| New | +$110K |
2023 Q4
0 quarters
|
|
5402
Franklin US Treasury Bond ETF
FLGV
$1.02B
| $123K | ﹤0.01% |
5,885
+4,651
| +377% | +$93.7K |
2023 Q3
1 quarter
|
|
|
IBDP
5403
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
| $122K | ﹤0.01% |
4,916
+4,393
| +840% | +$109K |
2019 Q4
16 quarters
|
|
5404
Emergent Biosolutions
EBS
$323M
| $122K | ﹤0.01% |
50,957
-242
| -0.5% | -$569 |
2014 Q1
39 quarters
|
|
5405
CALL
Amylyx Pharmaceuticals
AMLX
$3.55B
| $122K | ﹤0.01% |
+8,300
| New | +$127K |
2023 Q4
0 quarters
|
|
5406
First Trust Indxx NextG ETF
NXTG
$575M
| $122K | ﹤0.01% |
1,584
-77
| -5% | -$5.44K |
2021 Q3
9 quarters
|
|
5407
Clover Health Investments
CLOV
$2.33B
| $121K | ﹤0.01% |
127,121
+125,400
| +7,286% | +$123K |
2021 Q2
10 quarters
|
|
5408
Tilly's
TLYS
$139M
| $120K | ﹤0.01% |
15,952
+580
| +4% | +$4.67K |
2015 Q1
35 quarters
|
|
5409
Maui Land & Pineapple Co
MLP
$309M
| $119K | ﹤0.01% |
7,516
+2,621
| +54% | +$38.6K |
2017 Q4
24 quarters
|
|
5410
PUT
Baidu
BIDU
$28.7B
| $119K | ﹤0.01% |
1,000
| – | – |
2020 Q3
13 quarters
|
|
5411
Sportsman's Warehouse
SPWH
$43.1M
| $119K | ﹤0.01% |
27,885
+2,827
| +11% | +$13.4K |
2017 Q3
25 quarters
|
|
5412
Mayville Engineering Co
MEC
$421M
| $118K | ﹤0.01% |
8,212
+1,011
| +14% | +$12.5K |
2019 Q2
18 quarters
|
|
5413
BlackRock Income Trust
BKT
$312M
| $118K | ﹤0.01% |
9,714
+9,657
| +16,942% | +$110K |
2023 Q3
1 quarter
|
|
5414
Immuneering
IMRX
$263M
| $118K | ﹤0.01% |
16,074
-4,285
| -21% | -$28.5K |
2021 Q3
9 quarters
|
|
|
TRML
5415
DELISTED
Tourmaline Bio
TRML
| $118K | ﹤0.01% |
4,508
-34,305
| -88% | -$687K |
2021 Q2
10 quarters
|
|
5416
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$696M
| $118K | ﹤0.01% |
1,819
-9
| -0.5% | -$529 |
2022 Q4
4 quarters
|
|
5417
Puma Biotechnology
PBYI
$501M
| $118K | ﹤0.01% |
27,194
+27,135
| +45,992% | +$89.9K |
2013 Q2
42 quarters
|
|
5418
Fresenius Medical Care
FMS
$11.8B
| $118K | ﹤0.01% |
5,642
-1,359
| -19% | -$26.1K |
2013 Q2
42 quarters
|
|
5419
Neuropace
NPCE
$443M
| $117K | ﹤0.01% |
+11,360
| New | +$90.6K |
2023 Q4
0 quarters
|
|
5420
KLX Energy Services
KLXE
$29.5M
| $117K | ﹤0.01% |
10,355
+1,924
| +23% | +$19.5K |
2022 Q4
4 quarters
|
|
5421
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.29B
| $116K | ﹤0.01% |
3,395
-4,704
| -58% | -$153K |
2023 Q1
3 quarters
|
|
5422
PUT
Nasdaq
NDAQ
$50.6B
| $116K | ﹤0.01% |
+2,000
| New | +$105K |
2023 Q4
0 quarters
|
|
|
TGAN
5423
DELISTED
Transphorm, Inc. Common Stock
TGAN
| $116K | ﹤0.01% |
31,772
+14,249
| +81% | +$39K |
2022 Q1
7 quarters
|
|
|
LLAP
5424
DELISTED
Terran Orbital Corporation
LLAP
| $115K | ﹤0.01% |
101,275
+46,005
| +83% | +$38.5K |
2022 Q2
6 quarters
|
|
5425
Capital Group US Multi-Sector Income ETF
CGMS
$5.31B
| $115K | ﹤0.01% |
+4,268
| New | +$111K |
2023 Q4
0 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.